Aguilar RF, León MA

Language: Spanish
References: 26
Page: 117-124
PDF size: 158.29 Kb.

ABSTRACT

Background: The pathogenesis of chronic tension-headache an migraine remains unclear, and role of muscle tension is specially controversial. Botulinum toxin type A, a potent inhibitor of muscle tone, has been used to treat chronic tension-type headache and migraine. Objective: To inform the clinical response to treatment of chronic tension-type headache and migraine with botulinum toxin type A parallels changes in resting muscle activity with or not recorded through serial electromyography (EMG). Methods: We review mainly aspects about chronic tension-type headache and migraine to pericranial injection of botulinum toxin A. The revision include pathogenesis, neurotransmitters, updated treatment preventive and acute pain headache. Finally doses and places of injection. Conclusion: These review support the hypothesis that peripheral mechanisms such as increased muscle tone playin pathogenesis, beside, a minor role in the pathophysiology of chronic tension-type headache and migraine, and permit to drive at physician to have a correct decision for a novel treatment.

REFERENCES

1. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8(Suppl. 7): 196.

2. Siberstein SD. Chronic daily headache and tension-type headache. Neurology 1993; 43: 1644 9.

3. Rassmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population a prevalence study. J Clin Epidemiol 1991; 44:1147-57

4. Newman LC, Lipton RB, Solomon S et al. Daily headache in a population sample: results from the American Migraine Study. Headache 1994; 34(1): 295.

5. Rasmussen BK. Migraine and tension type headache in a general population: psychosocial factors. Int J Epidemiol 1992; 21:1138-43.

6. Friedman AP, Von Storch TJC, Merritt HH. Migraine and tension headaches. A clinical study: 2000 cases. Neurology 1964; 4: 773.

7. Ziegler DK, Hassanein R, Hassanein K. Headache syndromes suggested by factor analysis of symptom variables in a headache prone population. J Chron Dis 1972; 25:353-63.

8. Drummond PD. Scalp tenderness and sensitivity to pain in migraine and tension headache. Headache. 1987; 27:45-50.

9. Langemark M, Olesen J, Poulsen DL, Bech P. Clinical characterization of patients with chronic tension headache. Headache. 1988; 28:590-6.

10. Hatch JP, Moore PJ. Cyr-Provost M, et al. The use of electromyography and muscle palpation in the diagnosis of tension-type headache with and without pericranial muscle involvement. Pain 1992; 49:175-8.

11. Featherstone HJ. Migraine and muscle contraction headaches: a continuum. Headache 1985; 25:194-8.

12. Marcus DA. Migraine and tension-type headaches: the questionable validity of current classification systems. Clin J Pain 1992; 8:28-36.

13. Wolff HG. Muscles of the head and neck as sources of headache and other pain. In: Headache and other Head Pain. 2nd edition. New York: Oxford University Press, 1963; 582-616.

14. Strain JD, Strife JL, Kushner DC, Babcock DS, Cohen HL, Gelfand MJ, et al. Headache. American College of Radiology (ACR). Appropriateness criteria. Radiology 2000;215 (suppl):855-60.

15. Hershey AD, Powers SW, Bentti AL, LeCates S, DeGrauw TJ. Characterization of Chronic daily headaches in children in a multidisciplinary headache center. Neurology 2001;56(8):1032-7.

16. Zuart JA, Bovin G, Sand T, Sjaastad O. Tension Headache: botulinum toxin paralysis of temporal muscles. Headache 1994;34:458-462.

17. Hobson DE, Gladish DF. Botulinum toxin injection for cervicogenic headache. Headache 1997;37:253-255.

18. Wheeler AH. Botulinum toxin A, adjunctive therapy for refractory headaches associated with pericranial muscle tension. Headache 1998;38:468-71.

19. Schulte-Mattler WJ, Wieser T, Zierz S. Treatment of type tension headache with botulinum toxin: a pilot study. Eur J Med Res 1999;4:183-186.

20. Carruthers A, Langtry JA, Carruthers J, Robinson G. Improvement of Tension-type. Headache 1999;39:662-665.

21. Freund BJ, Schwartz M. Treatment of chronic cervical-associated headache with botulinum toxin A: a pilot study. Headache 200;40:231-236.

22. RollniK JD, Tanneberger O. Schubert M. Schneider U, Dengler R. Treatment of tension-type headache with botulinum toxin type A; a double blind, placebo-controlled study. Headache 2000;40:300-305.

23. Globel H, Heinze A, Heinze-Kuhn K, Jost WH. Evidence-based medicine: botulinum toxin A in migrainen and tension-type headache. J Neurol 2001;248:34-38.

24. Schmitt WJ, Slowey E, Fravi N, Weber S, Burgunder JM. Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial. Headache 2001; 41:658-664.

25. Silberstein SD. Review of botulinum toxin type A and clinical applications in migraine headache. Expert Opin Pharmacother 2001; 2: 1649-1654.

26. Alam M, Arndt KA, Dovers JS. Severe, intractable headache after injection with botulinum a exotoxin: report of 5 cases. J Am Dermatol 2002;46:62-65.